Sheridan completed her Ph.D. in Biomedical Engineering at Duke University. During her Ph.D., Sheridan investigated enhancing CAR T cell therapy in mouse EGFRvIII heterogenous glioblastoma. She is currently a postdoctoral fellow focused on various cancer immunotherapies at the University of Chicago in the labs of Dr. Melody Swartz and Dr. Jeffrey Hubbell.
Sheridan Swan, Ph.D.
-
PI : Jeffrey Hubbell and Melody Swartz
- Contact: sswan@uchicago.edu